Centre de Procréation Médicalement Assistée - ULiège, Centre Hospitalier Universitaire de Liège, Liège, Belgium.
IVF-Centers Prof. Zech, Bregenz, Austria.
J Assist Reprod Genet. 2018 Jun;35(6):1113-1121. doi: 10.1007/s10815-018-1167-8. Epub 2018 Apr 2.
The aim of this study was to compare the effect of the deselection of spermatozoa presenting vacuole-like structures using IMSI (intracytoplasmic morphologically selected sperm injection) with ICSI (intracytoplasmic sperm injection) by means of neonatal outcomes.
In a retrospective two-center analysis, a total of 848 successful IMSI or ICSI cycles ending with a live birth, induced abortion, or intrauterine fetal death (IUFD) were included.
The IMSI and ICSI groups included 332 and 655 babies or fetuses, respectively. The parents were older in the IMSI group than in the ICSI group (mothers were 35.1 vs 32.9 years, and fathers were 39.1 vs 36.2 years). The multiple pregnancy rate was higher in the IMSI group. The mean pregnancy duration and mean birth weight were almost identical in both groups. There was no significant difference in major congenital malformations between the two groups. However, this rate was decreased in the IMSI group compared to that in the ICSI group (1.8 vs 3.2%), the difference being mainly found in singletons (1.4 vs 3.3%). Boys were more often affected than girls in both groups. The percentages of chromosomal abnormalities did not differ between the IMSI and ICSI groups (0.6 and 0.8%). The reported congenital malformations mainly affected the heart, urogenital, and musculoskeletal systems.
In the present study, the malformation rates observed in the IMSI and ICSI groups were not significantly different, even if slightly lower after IMSI. However, the observed difference followed the same trends observed in previous reports, indicating the possible impact of IMSI on decreasing congenital malformation occurrences. This highlights the necessity to prospectively evaluate the impact of IMSI on neonatal outcome after IVF treatment.
本研究旨在比较使用 IMSI(卵胞浆内形态选择精子注射)与 ICSI(卵胞浆内单精子注射)对精子进行空泡样结构选择对新生儿结局的影响。
在一项回顾性的双中心分析中,共纳入了 848 例成功的 IMSI 或 ICSI 周期,这些周期以活产、流产或宫内胎儿死亡(IUFD)结束。
IMSI 和 ICSI 组分别包括 332 例和 655 例婴儿或胎儿。IMSI 组的父母年龄大于 ICSI 组(母亲分别为 35.1 岁和 32.9 岁,父亲分别为 39.1 岁和 36.2 岁)。IMSI 组的多胎妊娠率较高。两组的平均妊娠持续时间和平均出生体重几乎相同。两组之间主要先天性畸形的发生率没有差异。然而,与 ICSI 组相比,IMSI 组的发生率降低(1.8%比 3.2%),差异主要见于单胎(1.4%比 3.3%)。两组中男孩的受影响比例均高于女孩。两组的染色体异常率无差异(0.6%和 0.8%)。报告的先天性畸形主要影响心脏、泌尿生殖和肌肉骨骼系统。
在本研究中,IMSI 和 ICSI 组观察到的畸形率没有显著差异,即使 IMSI 后略有降低。然而,观察到的差异遵循了与之前报告相同的趋势,表明 IMSI 可能对降低先天性畸形的发生有影响。这强调了有必要前瞻性评估 IMSI 对体外受精治疗后新生儿结局的影响。